The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10188738 B1

PDF
Full Text
Expired
Date of Patent:
Jan. 29, 2019

Filed:

Oct. 16, 2014
Applicant:

Université Libre DE Bruxelles, Brussels, BE;

Inventors:

Karim Amighi, Brussels, BE;

Rémi Rosière, Wezembeek-Oppem, BE;

Nathalie Wauthoz, Tournai, BE;

Michel Gelbecke, Uccle, BE;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/51 (2006.01); A61K 31/337 (2006.01); A61K 31/495 (2006.01); A61K 33/24 (2006.01); A61K 9/00 (2006.01); A61K 9/50 (2006.01); A61K 47/48 (2006.01); A61K 47/55 (2017.01); A61K 47/61 (2017.01); A61K 47/69 (2017.01);
U.S. Cl.
CPC ...
A61K 47/48107 (2013.01); A61K 9/0075 (2013.01); A61K 9/50 (2013.01); A61K 9/5089 (2013.01); A61K 9/51 (2013.01); A61K 9/5123 (2013.01); A61K 9/5161 (2013.01); A61K 9/5192 (2013.01); A61K 31/337 (2013.01); A61K 31/495 (2013.01); A61K 33/24 (2013.01); A61K 47/551 (2017.08); A61K 47/61 (2017.08); A61K 47/6927 (2017.08); A61K 47/6939 (2017.08);
Abstract

The present application provides a pharmaceutical formulation comprising a folate receptor (FR)-targeting antineoplastic substance or composition, wherein the pharmaceutical formulation is configured for administration by inhalation, wherein the FR-targeting antineoplastic substance or composition is comprised in a nanoparticle and wherein the nanoparticles are comprised in microparticles, and its use in the treatment of a proliferative disease affecting at least part of the respiratory tract. The present application further provides a pharmaceutical formulation comprising an antineoplastic agent and a FR-targeting excipient, for use in the treatment of a proliferative disease affecting at least part of the respiratory tract.


Find Patent Forward Citations

Amighi, Karim. (2019). Formulations useful in the treatment of proliferative diseases affecting the respiratory tract (U.S. Patent No. 10188738). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10188738

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…